tradingkey.logo
搜索

Progyny Inc

PGNY
添加自选
31.130USD
-0.360-1.14%
收盘 07-31 16:00美东报价延迟15分钟
2.44B总市值
38.60市盈率 TTM

关于 Progyny Inc 公司

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Progyny Inc简介

公司代码PGNY
公司名称Progyny Inc
上市日期Oct 25, 2019
CEOAnevski (Peter)
员工数量675
证券类型Ordinary Share
年结日Oct 25
公司地址1359 Broadway
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10018
电话12128883124
网址https://www.progyny.com/
公司代码PGNY
上市日期Oct 25, 2019
CEOAnevski (Peter)

Progyny Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
11.27K
-10.95%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
5.38K
-15.24%
Mr. David Schlanger
Mr. David Schlanger
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Norman C. Payson, M.D.
Dr. Norman C. Payson, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--

常见问题

Progyny Inc的前五大股东是谁?

Progyny Inc 的前五大股东如下:Mr. Peter (Pete) Anevski

有多少机构持有Progyny Inc(PGNY)的股份?

截至2026Q1,共有790家机构持有Progyny Inc的股份,合计持有的股份价值约为88.51M,占公司总股份的113.05%。与2025Q4相比,机构持股有所增加,增幅为-31976779.00。

哪个业务部门对Progyny Inc的收入贡献最大?

在2026Q1,Fertility benefits services revenue业务部门对Progyny Inc的收入贡献最大,创收830.93M,占总收入的64.48%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有